Skip to main content Help with accessibility Skip to main navigation

NALDEMEDINE tablets (Rizmoic®▼) for treatment of opioid-induced constipation

CCG Approval Status:

Date Added: 16 - Jan - 2020
Grey

The Pan Mersey Area Prescribing Committee does not currently recommend the prescribing of NALDEMEDINE tablets (Rizmoic®▼) for the treatment of opioid-induced constipation.